Experienced. Dedicated. Determined.

The team at Meissa is dedicated and determined to advance life-saving vaccines against respiratory viruses. Our team brings more than 200 years of experience from discovery to commercial stage for vaccine development. Collectively our team has completed more than 100 clinical trials and been involved in the development of 15 approved products.

Meissa Vaccines - Chosen-30 website.jpeg

Kenneth J. Kelley, MBA

Executive Director

Isaac Cheng, M.D.


Marty Moore Ph.D.

Founder and Chief Executive Officer

Dr. Mike Watson


Stephanie Monaghan O'Brien, J.D.